Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000710783 | SCV000516946 | likely benign | not provided | 2024-09-17 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
ARUP Laboratories, |
RCV000440701 | SCV000603114 | likely benign | not specified | 2019-06-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001080558 | SCV000627332 | benign | Osteogenesis imperfecta type I; Ehlers-Danlos syndrome, classic type, 1 | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000710783 | SCV000703498 | uncertain significance | not provided | 2016-12-19 | criteria provided, single submitter | clinical testing | |
Center for Human Genetics, |
RCV000659368 | SCV000781179 | likely benign | Connective tissue disorder | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000710783 | SCV000841087 | benign | not provided | 2017-11-16 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001159491 | SCV001321209 | benign | Osteogenesis imperfecta | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV001159492 | SCV001321210 | likely benign | Ehlers-danlos syndrome, arthrochalasia type, 2 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Genome Diagnostics Laboratory, |
RCV001159491 | SCV002564791 | likely benign | Osteogenesis imperfecta | 2021-04-07 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002278662 | SCV002565582 | likely benign | Ehlers-Danlos syndrome | 2021-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002446665 | SCV002754115 | likely benign | Cardiovascular phenotype | 2019-05-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome Diagnostics Laboratory, |
RCV000710783 | SCV001807438 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000710783 | SCV001968285 | likely benign | not provided | no assertion criteria provided | clinical testing |